LIXT logo

LIXT Working Capital

Annual Working Capital

$3.99 M
-$1.17 M-22.66%

December 31, 2023


Summary


Performance

LIXT Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLIXTbalance sheetmetrics:

Quarterly Working Capital

$1.36 M
-$886.10 K-39.45%

September 30, 2024


Summary


Performance

LIXT Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLIXTbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

LIXT Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-22.7%0.0%
3 y3 years-20.3%-49.5%
5 y5 years-3.1%-49.5%

LIXT Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-22.7%at low-81.8%at low
5 y5-year-22.7%+64.1%-82.2%+40.7%
alltimeall time-22.7%+1334.1%-82.2%+520.1%

Lixte Biotechnology Holdings Working Capital History

DateAnnualQuarterly
Sep 2024
-
$1.36 M(-39.5%)
Jun 2024
-
$2.25 M(-28.2%)
Mar 2024
-
$3.13 M(-21.7%)
Dec 2023
$3.99 M(-22.7%)
$3.99 M(-18.9%)
Sep 2023
-
$4.92 M(+82.8%)
Jun 2023
-
$2.69 M(-34.0%)
Mar 2023
-
$4.08 M(-21.0%)
Dec 2022
$5.17 M(+7.8%)
$5.17 M(-19.4%)
Sep 2022
-
$6.41 M(-14.4%)
Jun 2022
-
$7.49 M(+116.4%)
Mar 2022
-
$3.46 M(-27.7%)
Dec 2021
$4.79 M(-4.4%)
$4.79 M(-20.8%)
Sep 2021
-
$6.05 M(-11.9%)
Jun 2021
-
$6.87 M(-10.2%)
Mar 2021
-
$7.65 M(+52.6%)
Dec 2020
$5.01 M(+105.9%)
$5.01 M(+418.5%)
Sep 2020
-
$966.60 K(-39.2%)
Jun 2020
-
$1.59 M(-22.4%)
Mar 2020
-
$2.05 M(-15.7%)
Dec 2019
$2.43 M(-41.0%)
$2.43 M(-11.7%)
Sep 2019
-
$2.76 M(-18.8%)
Jun 2019
-
$3.40 M(-8.5%)
Mar 2019
-
$3.71 M(-10.0%)
Dec 2018
$4.12 M(+314.4%)
$4.12 M(<-9900.0%)
Sep 2018
-
-$18.70 K(-107.9%)
Jun 2018
-
$237.60 K(-61.4%)
Mar 2018
-
$615.90 K(-38.1%)
Dec 2017
$995.10 K(+363.5%)
$995.10 K(-28.7%)
Sep 2017
-
$1.39 M(-23.5%)
Jun 2017
-
$1.82 M(+173.7%)
Mar 2017
-
$666.10 K(+210.2%)
Dec 2016
$214.70 K(-31.3%)
$214.70 K(-70.9%)
Sep 2016
-
$738.00 K(-40.4%)
Jun 2016
-
$1.24 M(+20.1%)
Mar 2016
-
$1.03 M(+230.5%)
Dec 2015
$312.30 K
$312.30 K(-61.2%)
Sep 2015
-
$804.90 K(-39.3%)
Jun 2015
-
$1.33 M(-7.1%)
DateAnnualQuarterly
Mar 2015
-
$1.43 M(+437.0%)
Dec 2014
$265.90 K(+12.6%)
$265.90 K(-55.2%)
Sep 2014
-
$593.90 K(-39.1%)
Jun 2014
-
$975.00 K(-1112.5%)
Mar 2014
-
-$96.30 K(-140.8%)
Dec 2013
$236.20 K(-84.2%)
$236.20 K(-59.3%)
Sep 2013
-
$580.30 K(-34.0%)
Jun 2013
-
$878.70 K(-27.4%)
Mar 2013
-
$1.21 M(-18.8%)
Dec 2012
$1.49 M(+1786.0%)
$1.49 M(-13.0%)
Sep 2012
-
$1.72 M(-9.9%)
Jun 2012
-
$1.90 M(-816.9%)
Mar 2012
-
-$265.50 K(-435.7%)
Dec 2011
$79.10 K(-95.4%)
$79.10 K(-87.6%)
Sep 2011
-
$638.10 K(-41.1%)
Jun 2011
-
$1.08 M(-21.8%)
Mar 2011
-
$1.39 M(-20.2%)
Dec 2010
$1.74 M(+33.5%)
$1.74 M(+0.9%)
Sep 2010
-
$1.72 M(-6.5%)
Jun 2010
-
$1.84 M(-13.6%)
Mar 2010
-
$2.13 M(+63.8%)
Dec 2009
$1.30 M(-501.9%)
$1.30 M(-567.0%)
Sep 2009
-
-$278.60 K(+266.6%)
Jun 2009
-
-$76.00 K(-47.0%)
Mar 2009
-
-$143.50 K(-55.7%)
Dec 2008
-$323.70 K(-186.0%)
-$323.70 K(+92.1%)
Sep 2008
-
-$168.50 K(-1618.0%)
Jun 2008
-
$11.10 K(-92.5%)
Mar 2008
-
$147.20 K(-60.9%)
Dec 2007
$376.20 K(-39.9%)
$376.20 K(+1201.7%)
Sep 2007
-
$28.90 K(-83.1%)
Jun 2007
-
$171.40 K(-49.3%)
Mar 2007
-
$338.20 K(-45.9%)
Dec 2006
$625.50 K(-4084.1%)
$625.50 K(-15.6%)
Sep 2006
-
$741.40 K(+1071.2%)
Jun 2006
-
$63.30 K(-739.4%)
Mar 2006
-
-$9900.00
Dec 2005
-$15.70 K
-

FAQ

  • What is Lixte Biotechnology Holdings annual working capital?
  • What is the all time high annual working capital for Lixte Biotechnology Holdings?
  • What is Lixte Biotechnology Holdings annual working capital year-on-year change?
  • What is Lixte Biotechnology Holdings quarterly working capital?
  • What is the all time high quarterly working capital for Lixte Biotechnology Holdings?
  • What is Lixte Biotechnology Holdings quarterly working capital year-on-year change?

What is Lixte Biotechnology Holdings annual working capital?

The current annual working capital of LIXT is $3.99 M

What is the all time high annual working capital for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high annual working capital is $5.17 M

What is Lixte Biotechnology Holdings annual working capital year-on-year change?

Over the past year, LIXT annual working capital has changed by -$1.17 M (-22.66%)

What is Lixte Biotechnology Holdings quarterly working capital?

The current quarterly working capital of LIXT is $1.36 M

What is the all time high quarterly working capital for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high quarterly working capital is $7.65 M

What is Lixte Biotechnology Holdings quarterly working capital year-on-year change?

Over the past year, LIXT quarterly working capital has changed by $0.00 (0.00%)